Monographie - Gemcitabine hydrochloride

Pēdējā atjaunošana :
03/05/2024

Gemcitabine hydrochloride

Ķīmiskā uzbūve

Oriģinālais nosaukums

Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām

Accogem	Meksika
Antoril	Argentīna
Axigem	Vācija
Bendacitabin	Vācija
Binoptos	Meksika
Celzar	Peru
Dercin	Rumānija
Dhacibine	Malaizija
Emcitab	Kolumbija
Eriogem	Argentīna, Ekvadora
Fotinex	Argentīna, Peru
Gebina	Argentīna
Gebitan	Kolumbija
Gembio	Argentīna, Čīle, Ekvadora
Gemcimira	Čīle, Peru
Gemcit	Portugāle
Gemcitabin	Vācija
Gemcitac	Čīle
Gemko	Turcija
Gemsibin	Turcija
Gemsol	Austrija
Gemtero	Čīle, Peru
Gemzar	Amerikas Savienotās Valstis, Apvienotie Arābu Emirāti, Austrālija, Austrija, Beļģija, Brazīlija, Čīle, Dānija, Dienvidāfrikas Republika, Ēģipte, Ekvadora, Francija, Grieķija, Holande, Horvātija, Irāna, Īrija, Islande, Itālija, Jaunzēlande, Kanāda, Kolumbija, Lielbritānija, Luksemburga, Malaizija, Maroka, Meksika, Norvēģija, Polija, Portugāle, Rumānija, Slovēnija, Somija, Spānija, Šveice, Taizeme, Tunisija, Turcija, Ungārija, Vācija, Venecuēla, Zviedrija
Gentabin	Kolumbija
Haxanit	Argentīna, Peru
Lenfotabin	Meksika

Literatūras saraksts : Gemcitabine hydrochloride

	Tips	Publicēšana
1422	Žurnāls	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Žurnāls	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Žurnāls	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Laboratorija	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Žurnāls	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Žurnāls	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Žurnāls	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Žurnāls	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Žurnāls	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Žurnāls	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Žurnāls	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Žurnāls	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Žurnāls	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Laboratorija	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Žurnāls	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Laboratorija	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Žurnāls	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Žurnāls	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Žurnāls	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales